MALOBERTI, THAIS
 Distribuzione geografica
Continente #
AS - Asia 5.308
NA - Nord America 2.689
EU - Europa 2.443
SA - Sud America 250
AF - Africa 243
Continente sconosciuto - Info sul continente non disponibili 189
OC - Oceania 8
Totale 11.130
Nazione #
US - Stati Uniti d'America 2.562
VN - Vietnam 1.778
IT - Italia 1.406
CN - Cina 1.265
SG - Singapore 1.060
HK - Hong Kong 315
KR - Corea 279
BR - Brasile 192
NL - Olanda 185
DE - Germania 168
BD - Bangladesh 155
FR - Francia 122
IN - India 111
FI - Finlandia 87
CI - Costa d'Avorio 86
JP - Giappone 86
SE - Svezia 82
GB - Regno Unito 78
CA - Canada 77
SC - Seychelles 63
IE - Irlanda 53
RU - Federazione Russa 44
PH - Filippine 41
CH - Svizzera 40
ID - Indonesia 37
PK - Pakistan 35
ZA - Sudafrica 29
PL - Polonia 26
AT - Austria 24
BG - Bulgaria 24
MX - Messico 23
TR - Turchia 23
ES - Italia 22
JO - Giordania 22
AR - Argentina 20
IQ - Iraq 18
TH - Thailandia 16
TW - Taiwan 16
DZ - Algeria 14
EC - Ecuador 14
MK - Macedonia 12
TG - Togo 10
CZ - Repubblica Ceca 9
VE - Venezuela 9
AU - Australia 8
GR - Grecia 8
IR - Iran 8
KE - Kenya 7
LT - Lituania 7
NG - Nigeria 7
SA - Arabia Saudita 7
BE - Belgio 6
RO - Romania 6
UA - Ucraina 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
JM - Giamaica 5
MY - Malesia 5
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
MA - Marocco 4
SN - Senegal 4
TT - Trinidad e Tobago 4
UG - Uganda 4
AL - Albania 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
MD - Moldavia 3
NP - Nepal 3
PT - Portogallo 3
SI - Slovenia 3
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
IS - Islanda 2
KZ - Kazakistan 2
LB - Libano 2
ML - Mali 2
MQ - Martinica 2
NO - Norvegia 2
OM - Oman 2
PY - Paraguay 2
RS - Serbia 2
SR - Suriname 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
Totale 10.927
Città #
Singapore 761
Hefei 580
Ho Chi Minh City 526
Ashburn 471
Bologna 445
Hanoi 421
Hong Kong 296
Seoul 270
San Jose 235
Los Angeles 151
Dallas 124
Milan 118
Council Bluffs 108
New York 103
Santa Clara 92
Beijing 87
Abidjan 86
Da Nang 78
Rimini 77
Boardman 76
Tokyo 69
Helsinki 63
Haiphong 56
Bengaluru 52
Dublin 51
Chandler 48
Lauterbourg 46
Frankfurt am Main 43
São Paulo 43
Rome 42
Munich 39
Bern 32
Buffalo 30
Atlanta 29
Groningen 29
Chicago 28
Montreal 28
Turin 28
Biên Hòa 27
Thái Nguyên 26
Denver 25
Florence 25
Sofia 24
Houston 23
Johannesburg 23
Warsaw 23
Amman 22
Amsterdam 22
Jakarta 22
Naples 22
Shanghai 22
Can Tho 21
Hải Dương 21
Orem 21
Quận Bình Thạnh 21
Vũng Tàu 21
Ha Long 20
Russi 20
San Francisco 20
Pavia 19
Seattle 19
Brooklyn 18
London 18
Paris 18
Redondo Beach 17
Tongling 17
Bắc Ninh 16
Modena 16
Nuremberg 16
Princeton 16
Ninh Bình 15
Southend 15
Hyderabad 14
Bến Tre 13
Mexico City 13
Phoenix 13
Turku 13
Boston 12
Nha Trang 12
Pittsburgh 12
Vienna 12
Forlì 11
Guangzhou 11
Islamabad 11
Lahore 11
Lappeenranta 11
Phủ Lý 11
Redmond 11
Salt Lake City 11
Shenzhen 11
Stockholm 11
Điện Bàn 11
Baghdad 10
Chennai 10
Falkenstein 10
Lomé 10
Palermo 10
Quận Một 10
Rajshahi 10
San Lazzaro di Savena 10
Totale 6.867
Nome #
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 638
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 440
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 365
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 347
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 312
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 270
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 264
Analysis of MDM2 and TP53 genes in canine liposarcoma 260
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 250
Next-generation technologies in predictive molecular pathology of lung cancers 243
Immunomagnetic enrichment coupled to PAX8/TP53 molecular pathology approach increases sensitivity in the detection of ovarian cancer cells in ascites 235
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 233
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 227
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 213
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 211
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience 210
Cutaneous Melanoma with "Paradoxical" p16 Hyper-expression: Molecular and Immunohistochemical Analysis of an Exceedingly Rare Entity with a Focus on Regulator Molecules of the Cell Cycle 204
Relevance of ARID1A Mutations in Endometrial Carcinomas 199
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 196
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 194
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study 191
Multifocal Fibrosing Thyroiditis: an Under-recognized Mimicker of Papillary Thyroid Carcinoma 172
Morpho-molecular approach (NGS plus digital PCR) in diagnosis of malignant biliary strictures 172
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center 170
"Paradoxical" p16 overexpression in cutaneous melanoma: Molecular and immunohistochemical analysis of a rare phenomenon with a focus on cell cycle regulatory molecules 168
Mutations of NOTCH Genes as an Alternative Mechanism to Activate mTOR pathway in Low-grade Oncocytic Tumor (LOT) of the Kidney 167
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 165
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH 165
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 164
Exploring the Role of TERT in Thyroid Cancer: A Systematic Review 163
An exceptional case of primary ovarian angiosarcoma 159
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy 155
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 149
Integrated clinicopathological and molecular analysis of endometrial carcinoma: prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification 146
Endometriosis-Associated Ovarian Carcinomas: Histotypes and Molecular Profiling 143
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study 140
Morphologic and molecular diagnostic criteria of malignancies in biliary strictures. 139
Beyond histology: A tissue algorithm predictive of post-surgical recurrence in hepatocellular carcinomas, including TERT promoter mutation. 139
High-grade Endometrial Endometrioid Carcinoma: A Case Report of Complete Transdifferentiation to Pilomatrix-like Carcinoma 138
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report 137
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel 131
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler 130
SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses 130
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance 126
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype 113
Molecular alterations in pancreatic tumors 113
Performance and clinical utility of two targeted multigene panels for GIST molecular characterization 112
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region 111
Adult granulosa cell tumours of the testis analogous to ovarian counterparts are exceptionally rare: analysis of a multicentric series and review of the literature 105
EIF1AX mutations in thyroid nodules: analysis of a series of 1095 consecutive cases. 102
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC 101
Molecular Classification of Endometrial Carcinoma and Immune Phenotypes: an Integrated Approach to Improve Risk Stratification 96
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: Express the role of PIK3CA mutations 96
Corrigendum to “Exploring the role of TERT in thyroid cancer: A systematic review” [Crit. Rev. Oncol./Hematol. 213 (2025) 104792] (Critical Reviews in Oncology / Hematology (2025) 213, (S1040842825001805), (10.1016/j.critrevonc.2025.104792)) 95
RET and RAS Mutations in Medullary Thyroid Carcinoma (MTC) and Their Impact on Histologic Grade, Tumor Characteristics, and Clinical Outcome: An International Multicentric Study of 289 Patients 94
Plasma over tissue? Liquid biopsy in the management of gastrointestinal stromal tumors (GISTs) 93
Primary vulvar adenocarcinoma of intestinal type: Report of two cases showing molecular similarity with colorectal adenocarcinoma 92
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center 89
Ovarian mixed malignant Brenner-mucinous tumour: report of a unique case 85
Hepatocellular Carcinomas with Concomitant Mutations of TERT, TP53, and CTNNB1: Is There a Role for Artificial Intelligence? 81
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab 76
NRAS-mutated oncocytic benign liver lesion in an organ donor: Pitfalls and troubles in frozen section diagnosis and risk assessment 74
From Endometriosis to Ovarian Cancer: Revealing Molecular Changes in Neoplastic Progressionthrough NGS Panel Analysis 70
Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells 55
Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience 51
Late Recurrence of a Growing Teratoma Syndrome-Like Lesion in a 54-Year-Old Female Patient: A Follow-up Case Report 49
Genome-wide SNP-based Profiling of Loss of Heterozygosity Reveals Distinct Molecular Subgroup-specific Patterns in Gastrointestinal Stromal Tumors (GIST) 7
Totale 11.130
Categoria #
all - tutte 27.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.732


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 0 1 2 15 10 1 3 11 14 46 18
2022/2023662 18 28 17 42 63 44 21 54 144 49 83 99
2023/2024531 76 37 36 46 61 64 23 41 26 27 32 62
2024/20252.114 126 134 159 104 151 101 147 94 70 203 310 515
2025/20267.419 1.151 848 552 530 408 229 836 160 1.022 494 859 330
2026/2027234 234 0 0 0 0 0 0 0 0 0 0 0
Totale 11.130